Genmab A (GMAB) Operating Leases (2019 - 2026)
Genmab A's (GMAB) quarterly Operating Leases came in at $152.0 million in Q4 2025, up 5.56% YoY from $144.0 million in Q4 2024, and up 2.7% on a QoQ basis from $148.0 million in Q2 2025.
Genmab A (GMAB) Operating Leases (2019 - 2026) Analysis & Trends
Genmab A (GMAB) has 5 years of Operating Leases data on file, last reported at $152.0 million in Q4 2025.
- Quarterly Operating Leases rose 5.56% year-over-year to $152.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.0 million (up 5.56% YoY) and the FY2025 annual result came in at $152.0 million, up 5.56% from the prior year.
- Operating Leases improved to $152.0 million in Q4 2025, from $148.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $152.0 million in Q4 2025 to a low of $114.0 million in Q4 2023.
- A 3-year average of $140.2 million and a median of $144.0 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases gained 26.32% — and 2025, when it rose 5.56%.
- Tracing GMAB's Operating Leases over 3 years: stood at $114.0 million in 2023, then rose by 26.32% to $144.0 million in 2024, then rose by 5.56% to $152.0 million in 2025.
- The last three Operating Leases figures came in at $152.0 million (Q4 2025), $148.0 million (Q2 2025), and $143.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120.00 Mn |
| Dec 31, 2025 | 152.00 Mn |
| Jun 30, 2025 | 148.00 Mn |
| Mar 31, 2025 | 143.00 Mn |
| Dec 31, 2024 | 144.00 Mn |
| Dec 31, 2023 | 114.00 Mn |
| Sep 30, 2020 | 337.00 Mn |
| Dec 31, 2019 | 181.00 Mn |
| Sep 30, 2019 | 188.61 Mn |